DUBLIN, Ireland, April 30, 2019 (GLOBE NEWSWIRE) — Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company, will …


Link to Full Article: Read Here

Pin It on Pinterest

Share This